V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10450902 | 10034207 | 1.65 | 74 | Adjuvant (A) | 2017-11-06 | 2017-11-14 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101276919 |
| 10450913 | 10034208 | 1.75 | 82.3 | null | 2021-07-06 | 2021-07-11 | Rituximab | 02 | null | RITUXIMAB | 101690124 |
| 10450922 | 10034209 | 1.8 | 74.4 | 03 | 2017-03-07 | 2017-03-12 | Docetaxel | 02 | N | DOCETAXEL | 100574165 |
| 10450936 | 10034210 | 1.7 | 47.7 | Curative (C) | 2018-05-10 | 2018-05-20 | CAPECITABINE + OXALIPLATIN | 02 | N | PEMBROLIZUMAB | 100941783 |
| 10450947 | 10034211 | 1.53 | 71.6 | Neo-adjuvant (N) | 2015-05-21 | 2015-06-01 | Rituximab | 02 | N | RITUXIMAB | 100282059 |
| 10450966 | 10034212 | 1.63 | 69 | Disease modification (D) | 2021-04-05 | 2021-04-26 | PEMBROLIZUMAB | 02 | null | RITUXIMAB | 100452550 |
| 10450983 | 10034213 | 1.75 | 64.2 | Curative (C) | 2016-03-23 | 2016-04-07 | Rituximab | null | null | RITUXIMAB | 101446540 |
| 10450988 | 10034214 | 1.68 | 103 | Palliative (P) | null | 2017-05-26 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100485696 |
| 10450990 | 10034215 | 1.57 | 88.9 | Curative (C) | 2018-05-17 | 2018-05-17 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101505925 |
| 10451015 | 10034216 | 1.7 | 76 | null | 2019-02-27 | 2019-03-27 | IBRUTINIB | 02 | null | IBRUTINIB | 100130861 |
| 10451019 | 10034217 | 1.55 | null | 03 | 2019-11-26 | 2019-11-28 | IBRUTINIB | 02 | N | IBRUTINIB | 100588968 |
| 10451037 | 10034218 | 1.79 | 65.6 | Adjuvant (A) | 2018-07-14 | 2018-08-08 | Rituximab | 02 | N | RITUXIMAB | 100634462 |
| 10451058 | 10034220 | 1.82 | 67.5 | Palliative (P) | 2017-09-13 | 2017-09-20 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100689327 |
| 10451059 | 10034221 | 1.72 | 74 | null | 2020-04-07 | 2020-04-19 | CAPECITABINE + OXALIPLATIN | 99 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101477546 |
| 10451071 | 10034222 | 1.7 | 68.8 | Palliative (P) | 2018-10-12 | 2018-10-12 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100365155 |
| 10451081 | 10034223 | 1.67 | 57.1 | Palliative (P) | 2016-12-03 | 2016-12-03 | IBRUTINIB | N | N | IBRUTINIB | 100974264 |
| 10451108 | 10034224 | 1.83 | 79.2 | Curative (C) | 2019-05-13 | 2019-05-26 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101357986 |
| 10451112 | 10034225 | 1.52 | 103.9 | Neo-adjuvant (N) | 2017-01-26 | 2017-01-26 | IBRUTINIB | 02 | null | IBRUTINIB | 100138635 |
| 10451117 | 10034226 | 1.75 | 115.8 | 03 | 2017-09-26 | 2017-09-26 | Rituximab | 02 | N | RITUXIMAB | 100926496 |
| 10451122 | 10034227 | 1.8 | 79.6 | null | 2020-04-13 | 2020-04-23 | PEMBROLIZUMAB | N | null | PEMBROLIZUMAB | 101579607 |
| 10451136 | 10034228 | 1.77 | 58.8 | 03 | 2017-01-11 | 2017-01-19 | Docetaxel | 02 | N | DOCETAXEL | 100468079 |
| 10451151 | 10034229 | 1.61 | 55 | Curative (C) | 2018-07-07 | 2018-07-07 | Rituximab | null | null | RITUXIMAB | 100485957 |
| 10451160 | 10034230 | 1.57 | null | Palliative (P) | 2019-05-05 | 2019-05-05 | IBRUTINIB | 02 | N | IBRUTINIB | 101468305 |
| 10451162 | 10034231 | 1.81 | 59.3 | Adjuvant (A) | 2015-11-08 | 2015-11-11 | Rituximab | 02 | N | RITUXIMAB | 101161119 |
| 10451179 | 10034232 | 1.77 | 68.9 | null | 2020-07-28 | 2020-08-04 | CHOP R | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101306468 |
| 10451186 | 10034233 | 1.78 | 81.8 | Curative (C) | 2018-03-05 | 2018-03-12 | Rituximab | N | N | RITUXIMAB | 101655796 |
| 10451192 | 10034234 | 1.63 | 59.6 | Palliative (P) | 2017-07-28 | 2017-08-23 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101658479 |
| 10451193 | 10034235 | 1.81 | 96.6 | Adjuvant (A) | 2020-05-21 | 2020-05-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101419067 |
| 10451202 | 10034236 | 1.57 | 60.7 | Disease modification (D) | 2022-05-24 | 2022-05-27 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100214205 |
| 10451249 | 10034237 | 1.73 | 82 | 03 | 2017-10-13 | 2017-10-13 | Capecitabine | 02 | N | CAPECITABINE | 100811812 |
| 10451267 | 10034238 | 1.7 | 71.6 | null | null | 2016-06-14 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 101759049 |
| 10451295 | 10034239 | 1.74 | 69.8 | null | 2020-10-20 | 2020-11-09 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100250108 |
| 10451297 | 10034240 | 1.64 | 60 | null | 2021-11-07 | 2021-11-19 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100441648 |
| 10451299 | 10034241 | null | 89.1 | Curative (C) | 2016-07-08 | 2016-07-16 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101160094 |
| 10451300 | 10034242 | 1.66 | 86.2 | null | 2015-04-03 | 2015-04-03 | Rituximab | 02 | null | RITUXIMAB | 100001358 |
| 10451303 | 10034243 | null | 62.9 | null | 2019-06-09 | 2019-06-21 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101334028 |
| 10451306 | 10034244 | 1.69 | 87.2 | Neo-adjuvant (N) | 2018-09-20 | 2018-09-23 | IBRUTINIB | 02 | null | IBRUTINIB | 101580112 |
| 10451307 | 10034245 | 1.65 | 90.5 | Curative (C) | 2017-11-08 | 2017-12-05 | IBRUTINIB | 02 | N | IBRUTINIB | 100018074 |
| 10451317 | 10034246 | 1.75 | 101 | Adjuvant (A) | 2017-02-10 | 2017-02-10 | IBRUTINIB | 02 | N | IBRUTINIB | 100603556 |
| 10451326 | 10034247 | 1.72 | 84.8 | Palliative (P) | 2017-12-01 | 2017-12-15 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101857108 |
| 10451346 | 10034248 | 0 | 85.5 | Adjuvant (A) | 2019-05-08 | 2019-05-21 | IBRUTINIB | 02 | N | IBRUTINIB | 100455191 |
| 10451352 | 10034249 | 1.8 | null | Palliative (P) | 2020-12-21 | 2021-01-08 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100358689 |
| 10451353 | 10034250 | 1.79 | 94 | Curative (C) | 2016-11-17 | 2016-11-23 | CAPECITABINE + OXALIPLATIN | N | N | CAPECITABINE + OXALIPLATIN | 100906614 |
| 10451406 | 10034251 | 1.82 | 87 | Palliative (P) | 2018-07-09 | 2018-07-21 | Capecitabine | 02 | N | CAPECITABINE | 100810106 |
| 10451418 | 10034252 | 1.64 | 0 | null | 2019-12-09 | 2020-01-08 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 101055429 |
| 10451423 | 10034253 | 1.82 | 57.1 | Adjuvant (A) | 2018-01-21 | 2018-02-03 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100327851 |
| 10451463 | 10034254 | 1.82 | 0 | null | 2022-01-17 | 2022-01-30 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 101305049 |
| 10451465 | 10034255 | 1.74 | 78 | Palliative (P) | 2017-08-26 | 2017-08-30 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101425088 |
| 10451476 | 10034256 | 1.7 | 76.6 | Neo-adjuvant (N) | 2019-11-21 | 2019-12-15 | CAPECITABINE + RT | 2 | Y | CAPECITABINE | 100250938 |
| 10451492 | 10034257 | 1.6 | 123.7 | Adjuvant (A) | 2017-10-08 | 2017-10-10 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100832585 |